BeAM Value

ورودی‌های بالینی بیمار

حداقل ۴۰ — حداکثر ۶۰۰ • واحد: mg/dL

حداقل ۴۰ — حداکثر ۶۰۰ • واحد: mg/dL

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
beam value
—mg/dL
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • High BeAM30–1000
  • Medium/Low BeAM0–29
  • Negative BeAM-1000–-1
Direct Clinical Answer

The BeAM Value calculator is designed for bedside calculating the difference between bedtime and morning fasting blood glucose to guide prandial insulin therapy decisions in patients with type 2 diabetes in clinical practice. The resulting score directly guides clinician decision-making regarding titrating insulin infusion protocols.

Clinical Guidelines & Evidence

Calculates the difference between bedtime and morning fasting blood glucose to guide prandial insulin therapy decisions in patients with type 2 diabetes

Clinical Indication

The BeAM Value is indicated for bedside clinical practice to support Calculates the difference between bedtime and morning fasting blood glucose to guide prandial insulin therapy decisions in patients with type 2 diabetes. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.

Limitations & Contraindications

Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection. Clinical exclusion: Negative BeAM (<0 mg/dL) is a contraindication for intensification of prandial insulin therapy.

Clinical Pearls & Action Plan

Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management.

Formula & Variables:

BeAM Value = Bedtime glucose (mg/dL) - Morning fasting glucose (mg/dL)

Input Parameters

NameTypeRequiredDescription
bedtime_glucosefloatYesBedtime blood glucose level (SMBG measurement taken before sleep)(mg/dL)
morning_glucosefloatYesMorning fasting blood glucose level (SMBG measurement taken before breakfast)(mg/dL)

Score Interpretation & Guidance

RangeStageDescription
30–1000High BeAMLarge BeAM value (≥30 mg/dL)
0–29Medium/Low BeAMMedium/Low BeAM value (0-29 mg/dL)
-1000–-1Negative BeAMNegative BeAM value (<0 mg/dL)

Evidence-Based References (EBM)

  • Raz I, Wilson PW, Strojek K, Kowalska I, Bozikov V, Gitt AK, et al. Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care. 2009 Mar;32(3):381-6.
  • Blonde L, Merilainen M, Karwe V, Raskin P; TITRATE Study Group. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study. Diabetes Obes Metab. 2009 Jun;11(6):623-31.
  • Garber AJ, King AB, Del Prato S, Sreenan S, Balci MK, Muñoz-Torres M, et al. Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. Lancet. 2012 Apr 21;379(9825):1498-507.

Related calculators